C
Originally published by Capital Businessbusiness
April 3, 2026
3h ago
Pharmaceuticals face 100% tariffs in US – unless firms strike a deal
US President Donald Trump ordered the long-threatened levies on Thursday. The White House said the aim of the tariffs was to reduce national security risks by boosting manufacturing of key medicines in the US. Kenya breaking news | Kenya news today |..
✨ Key Highlights
The United States has ordered a 100% tariff on patented medicines entering the country, effective March 3, aiming to boost domestic manufacturing and reduce national security risks.
- Pharmaceutical companies can avoid the full tariff by striking deals with the US administration.
- Companies committing to US manufacturing before January 2029 face a 20% tariff, which drops to zero if pricing deals are reached.
- Many large drug-makers have already secured exemptions, with the goal of bringing remaining companies to the bargaining table.
Continue Reading
Read the complete article from Capital Business
Advertisement
Advertisement